PATENT CLAIM ANALYSIS

Application Number: 16157050
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-07
Patent Classification: ["424", "450000"]

Abstract:
Disclosed herein are pharmaceutical compositions that comprise “blends” of lipid nanoparticles and related methods of using such blended compositions to deliver polynucleotides to one or more target cells, tissues or organs. The blended compositions are generally characterized as being able to efficiently deliver polynucleotides to target cells and by their ability to enhance the expression of such polynucleotides and the production of functional proteins by target cells.

Claim (Index 90):
The method of  claims 83 , wherein the first mRNA encodes a protein or a peptide, and the protein or the peptide encoded by the first mRNA is secreted from one or more cells.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.53191
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14775818', '14124615', '15887693', '14959453', '15368280']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8101119447559746
- 35 USC 102 Novelty (BERT): 0.6357610606728848
- Combined Prediction Score: 0.7926768563476656
- Mean Citation Score: 512.98415
- Max Citation Score: 759.15955
- Similarity Product: 561.4136805373937

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test